RESTON, Va.--(BUSINESS WIRE)--The Clinical Research Information eXchange (CRIX) International today announced their participation with Pfizer, Partners HealthCare and the Clinical Data Interchange Standards Consortium (CDISC) in the ASTER (Adverse Drug Event Spontaneous Triggered Electronic Reporting) study, which is exploring ways to improve the current spontaneous reporting system (SRS), the primary source of information for adverse drug events. The ASTER study is exploring how a combination of standards, technology and a new business model can improve drug safety by helping physicians better recognize and report adverse events, and by improving the quality of data in safety reports.
